arrow
T

Takehiro Noda

The University of Osaka
H指数:36
被引数:4,430

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Self-assembling peptide hydrogel SPG-178 effectively prevents postoperative pancreatic fistula compared with polyglycolic acid mesh with fibrin glue in rats

与聚乙醇酸网片联合纤维蛋白胶相比,自组装肽水凝胶SPG-178可有效预防大鼠术后胰瘘

2026-10-150
OAAI
Relationship Between Radiographic and Pathological Portal Vein-Superior Mesenteric Vein Involvement in Neoadjuvant Treatment for Pancreatic Cancer: A Comparative Study of Neoadjuvant Chemotherapy and Chemoradiotherapy

胰腺癌新辅助治疗中影像学及病理学门静脉-肠系膜上静脉受侵的关系:新辅助化疗与化放疗的对比研究

2026-06-010
OAAI
Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA

外泌体miR-4800-3p通过靶向PLAA促进胰腺癌门静脉血中的肝转移

2026-04-190
OAAI
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders

日本患者黑色素瘤的基因组与转录组分析揭示了免疫检查点抑制剂应答者的候选生物标志物

2026-01-070
OAAI
Can preoperative spirometry be omitted for HBP surgery?

术前肺量测定能否在HBP手术中省略?

2026-01-010
PRE
Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease

Fontan相关肝病患者的肝细胞癌基因组与转录组分析

2026-01-010
PRE
Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma

肿瘤相关高内皮静脉与切除的肝细胞癌中淋巴细胞浸润增强及良好预后相关

2025-12-190
OAAI
Assessment of Surgical Invasiveness in Hepatobiliary and Pancreatic Surgeries by Quantifying Intraoperative Energy Expenditure: A Comparison Between Laparoscopic and Open Surgery

通过量化术中能量消耗评估肝胆胰手术的手术侵袭性:腹腔镜手术与开腹手术的比较

2025-12-040
PRE
Impact of diabetes mellitus and grip strength on postoperative outcomes in older patients undergoing cancer surgery: A single-center retrospective cohort study
2025-12-010
OAAI
IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts

肝切除术期间释放的IL-33通过癌症相关成纤维细胞中的细胞因子分泌促进肝内胆管癌生长。

2025-11-230
PRE
Prognostic significance of neoadjuvant gemcitabine and S-1 chemotherapy with or without concurrent radiation in patients with resectable and borderline resectable pancreatic cancer: A post hoc analysis of 2 phase II trials

可切除和临界可切除胰腺癌患者中,新辅助吉西他滨和S-1化疗联合或不联合同期放疗的预后意义:2项II期试验的事后分析

Surgery
IF2.7
2025-11-120
OAAI
Graft trimming with LigaSure™ and leak testing with Indigo carmine reduces blood loss significantly after reperfusion in pancreas transplantation

使用LigaSure™进行移植物修剪并用靛蓝胭脂红进行渗漏测试,可显著减少胰腺移植再灌注后的失血量。

2025-11-010
PRE
Pre-Operative Resistance Training and Amino Acid Supplementation in Frail Patients With Gastrointestinal Cancer: A Randomized Clinical Trial

术前抗阻训练与氨基酸补充在胃肠道癌症虚弱患者中的应用:一项随机临床试验

2025-10-013
OAAI
Response to the letter to the Editor: “Refining the Prognostic Utility of CA19-9 in Neoadjuvant Therapy for Pancreatic Cancer: Emphasizing Serial Monitoring and Subgroup Differentiation”

对致编辑信的回应:“优化CA19-9在胰腺癌新辅助治疗中的预后价值:强调系列监测和亚组区分”

2025-09-300
PRE
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL-4, Enhancing Tumor Growth in Hepatocellular Carcinoma

肿瘤内皮细胞通过IL-4诱导M2型巨噬细胞极化,增强肝细胞癌的生长

2025-08-270
OAAI
Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy

胰腺癌新辅助治疗中放射学与病理学反应评估的差异:新辅助化疗与新辅助化放疗的比较

2025-06-280
OAAI